Scarpini, Elio
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
47 papers on CoChatORCID 0000-0002-6395-2119
Most cited papers
- Verified
Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 179
- Verified
Heterozygous TREM2 mutations in frontotemporal dementia
Borroni, B., Ferrari, F., Galimberti, D., Nacmias, B., Barone, C., Bagnoli, S., Fenoglio, C., Piaceri, I., Archetti, S., Bonvicini, C., et al. (2014) · Neurobiology of Aging
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 173
- Verified
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
Pottier, C., Zhou, X., Perkerson, R. B., Baker, M., Jenkins, G. D., Serie, D. J., Ghidoni, R., Benussi, L., Binetti, G., López de Munain, A., et al. (2018) · The Lancet Neurology
Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments
Cited by 131
- Verified
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease
EADI consortium, G. C., Lambert, J.-C., Grenier-Boley, B., Harold, D., Zelenika, D., Chouraki, V, Kamatani, Y., Sleegers, K., Ikram, M. A., Hiltunen, M., et al. (2013) · Molecular Psychiatry
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 129
- Verified
Old and new acetylcholinesterase inhibitors for Alzheimer’s disease
Galimberti, D., & Scarpini, E. (2016) · Expert Opinion on Investigational Drugs
Cholinesterase and Neurodegenerative DiseasesAlzheimer's disease research and treatments
Cited by 117
- Verified
Epigenetic modulation of BDNF gene: Differences in DNA methylation between unipolar and bipolar patients
Dell׳Osso, B., D׳Addario, C., Carlotta Palazzo, M., Benatti, B., Camuri, G., Galimberti, D., Fenoglio, C., Scarpini, E., Di Francesco, A., Maccarrone, M., et al. (2014) · Journal of Affective Disorders
Bipolar Disorder and TreatmentEpigenetics and DNA Methylation
Cited by 112
- Verified
Pioglitazone for the treatment of Alzheimer’s disease
Galimberti, D., & Scarpini, E. (2017) · Expert Opinion on Investigational Drugs
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 106
- Verified
Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., Del Fabbro, M., Scarpini, E., & Galimberti, D. (2023) · International Journal of Molecular Sciences
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 94
- Verified
Innate immune system and inflammation in Alzheimer’s disease: From pathogenesis to treatment
Serpente, M., Bonsi, R., Scarpini, E., & Galimberti, D. (2014) · Neuroimmunomodulation
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 87
- Verified
α-MSH Peptides Inhibit Production of Nitric Oxide and Tumor Necrosis Factor-α by Microglial Cells Activated with β-Amyloid and Interferon γ
Galimberti, D., Baron, P., Meda, L., Prat, E., Scarpini, E., Delgado, R., Catania, A., Lipton, J. M., & Scarlato, G. (1999) · Biochemical and Biophysical Research Communications
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 83
- Verified
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
Borroni, B., Benussi, A., Archetti, S., Galimberti, D., Parnetti, L., Nacmias, B., Sorbi, S., Scarpini, E., & Padovani, A. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research
Cited by 77
- Verified
Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses
Paroni, M., Maltese, V., De Simone, M., Ranzani, V., Larghi, P., Fenoglio, C., Pietroboni, A. M., De Riz, M. A., Crosti, M. C., Maglie, S., et al. (2017) · Journal of Allergy and Clinical Immunology
Multiple Sclerosis Research StudiesT-cell and B-cell Immunology
Cited by 77
- Verified
IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
Saresella, M., Marventano, I., Piancone, F., La Rosa, F., Galimberti, D., Fenoglio, C., Scarpini, E., & Clerici, M. (2020) · Journal of Neuroinflammation
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 75
- Verified
An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders
Fenoglio, C., Ridolfi, E., Galimberti, D., & Scarpini, E. (2013) · International Journal of Molecular Sciences
Cancer-related molecular mechanisms researchRNA Research and Splicing
Cited by 68
- Verified
The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia
Galimberti, D., Reif, A., Dell'Osso, B., Kittel-Schneider, S., Leonhard, C., Herr, A., Palazzo, C., Villa, C., Fenoglio, C., Serpente, M., et al. (2014) · Neurobiology of Aging
Amyotrophic Lateral Sclerosis ResearchSchizophrenia research and treatment
Cited by 66
- Verified
Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers
Meeter, L. H. H., Gendron, T. F., Sias, A. C., Jiskoot, L. C., Russo, S. P., Donker Kaat, L., Papma, J. M., Panman, J. L., van der Ende, E. L., Dopper, E. G., et al. (2018) · Annals of Clinical and Translational Neurology
Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative Diseases
Cited by 61
- Verified
Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer’s Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study
Olde Rikkert, M. G. M., Verhey, F. R., Blesa, R., von Arnim, C. A. F., Bongers, A., Harrison, J., Sijben, J., Scarpini, E., Vandewoude, M. F. J., Vellas, B., et al. (2015) · Journal of Alzheimer s Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 61
- Verified
Treatment of Alzheimers Disease: Symptomatic and Disease-Modifying Approaches
Galimberti, D., & Scarpini, E. (2010) · Current Aging Science
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 51
- Verified
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder
Galimberti, D., Reif, A., Dell'Osso, B., Palazzo, C., Villa, C., Fenoglio, C., Kittel‐Schneider, S., Leonhard, C., Olmes, D. G., Serpente, M., et al. (2014) · Bipolar Disorders
Amyotrophic Lateral Sclerosis ResearchBipolar Disorder and Treatment
Cited by 36
- Verified
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes
Carandini, T., Arighi, A., Sacchi, L., Fumagalli, G. G., Pietroboni, A. M., Ghezzi, L., Colombi, A., Scarioni, M., Fenoglio, C., De Riz, M. A., et al. (2019) · Alzheimer's Research & Therapy
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 36
- Verified
Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing
Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory)
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 35
- Verified
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort
Foster, P. H., Russell, L. L., Peakman, G., Convery, R. S., Bouzigues, A., Greaves, C. V., Bocchetta, M., Cash, D. M., van Swieten, J. C., Jiskoot, L. C., et al. (2022) · Cortex
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 16
- Verified
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes
van Waalwijk van Doorn, L. J. C., Gispert, J. D., Kuiperij, H. B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., et al. (2017) · Journal of Alzheimer’s Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free